Travere Therapeutics, Inc. TVTX
59.44
(1.18)
(1.95%)
as of 25 Sep
- Market cap
- $5.7B
- P/E
- 0.0×
Follow TVTX
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
5.11 | 5.62 | 5.57 | 3.43 | 6.53 | 14.09 | 12.03 | 4.89 | 5.89 | 6.95 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(80.37) | (1,020.10) | (256.66) | (133.84) | (93.43) | (69.10) | (24.11) | (10.07) | (38.47) | 56.18 |
P/B ratio |
2.22 | 2.97 | 2.88 | 2.72 | 6.14 | 6.15 | 30.74 | 3.54 | 23.26 | 29.69 |
Price to Tangible BV |
5.47 | 8.11 | 7.00 | 9.53 | 22.70 | 12.09 | 0.00 | 7.37 | 0.00 | 3,550.82 |
EV/Sales |
3.53 | 3.97 | 3.89 | 2.32 | 5.80 | 11.61 | 11.35 | 3.58 | 5.63 | 6.92 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(136.93) | 83.16 | (25.58) | (7.00) | (26.90) | (103.49) | (6.67) | (1.86) | (5.53) | 89.92 |
EV/FCF |
(30.66) | (93.19) | (14.30) | (5.52) | (17.08) | (39.31) | (5.78) | (1.61) | (4.80) | (161.30) |
Quick Ratio |
3.30 | 3.67 | 4.63 | 4.38 | 4.26 | 4.58 | 3.28 | 3.31 | 1.98 | 2.52 |
Current Ratio |
3.99 | 3.80 | 4.74 | 4.50 | 4.43 | 4.70 | 3.42 | 3.47 | 2.08 | 2.74 |
Net Debt/EBITDA |
5.24 | 7.52 | 4.80 | 2.35 | 1.04 | 1.88 | 0.25 | 0.53 | 0.21 | 2.27 |
Debt/Assets |
8.46% | 8.66% | 27.51% | 33.87% | 35.45% | 29.17% | 55.84% | 47.82% | 52.23% | 51.51% |
Debt/Equity |
0.14 | 0.15 | 0.61 | 0.93 | 1.02 | 0.75 | 8.76 | 1.88 | 5.25 | 2.71 |
Asset Turnover |
0.26 | 0.30 | 0.27 | 0.27 | 0.33 | 0.19 | 0.15 | 0.20 | 0.34 | 0.82 |
Operating CF/Net income |
0.07 | (0.12) | 0.24 | 0.40 | 0.25 | 0.08 | 0.67 | 2.51 | 0.74 | (1.48) |
Capex/Depreciation |
(0.67) | (0.71) | (0.88) | (0.28) | (0.70) | (0.93) | (1.32) | (1.29) | (0.89) | (1.00) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (15.76%) | (19.88%) | (33.59%) | (54.29%) | (78.37%) | (70.17%) | (161.46%) | (91.44%) | (247.45%) | (29.38%) | |
| (9.23%) | (11.42%) | (16.70%) | (22.29%) | (27.95%) | (26.02%) | (38.43%) | (15.24%) | (46.50%) | (4.26%) | |
ROIC |
(37.78%) | (89.46%) | (119.67%) | (311.81%) | (169.48%) | 0.00% | 0.00% | (2,161.70%) | 0.00% | (37.84%) |
Return on Tangible Assets |
(19.03%) | (24.54%) | (26.05%) | (43.51%) | (51.79%) | (38.33%) | (78.82%) | (24.96%) | (145.31%) | (9.07%) |
Average Days of Receivables |
50.57 | 32.68 | 28.14 | 40.47 | 60.86 | 44.06 | 55.51 | 53.23 | 42.45 | 59.60 |
Research and Development Expense of Revenue |
53.01% | 50.45% | 75.35% | 80.40% | 66.44% | 152.58% | 207.69% | 168.68% | 121.24% | 41.98% |
Selling, General and Administrative Expense of Revenue |
68.82% | 65.40% | 63.11% | 73.54% | 68.47% | 95.79% | 180.45% | 182.83% | 113.27% | 68.71% |
Intangible Assets out of Total Assets |
0.35 | 0.36 | 0.26 | 0.26 | 0.25 | 0.19 | 0.14 | 0.13 | 0.18 | 0.19 |
Share Based Compensation of Revenue |
21.78% | 17.35% | 12.04% | 12.04% | 11.91% | 22.43% | 34.85% | 30.46% | 15.83% | 9.14% |
Graham Net Nets |
0.17 | 0.11 | 0.11 | 0.08 | 0.01 | 0.06 | (0.11) | 0.04 | (0.09) | (0.02) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(6.99%) | (6.85%) | (11.22%) | (24.37%) | (12.36%) | (9.76%) | (21.15%) | (16.84%) | (23.54%) | (0.76%) |
Free Cash Flow Yield |
(2.25%) | (0.76%) | (4.88%) | (12.27%) | (5.19%) | (2.10%) | (16.32%) | (45.39%) | (19.92%) | (0.62%) |
Revenue per Share |
3.61 | 4.00 | 4.06 | 4.14 | 4.17 | 2.20 | 1.72 | 1.96 | 2.96 | 5.50 |
Operating CF per Share |
(0.09) | 0.19 | (0.62) | (1.37) | (0.90) | (0.25) | (2.92) | (3.77) | (3.01) | 0.42 |
Capex per Share |
(0.32) | (0.36) | (0.49) | (0.37) | (0.52) | (0.40) | (0.45) | (0.57) | (0.46) | (0.65) |
Free Cash Flow per Share |
(0.42) | (0.17) | (1.10) | (1.74) | (1.42) | (0.65) | (3.37) | (4.34) | (3.47) | (0.23) |
Cash per Share |
6.92 | 7.75 | 11.66 | 9.41 | 7.61 | 9.24 | 7.06 | 7.63 | 4.70 | 3.62 |
Shareholders Equity per Share |
8.32 | 7.56 | 7.87 | 5.22 | 4.44 | 5.05 | 0.67 | 2.70 | 0.75 | 1.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.32 | 7.56 | 7.87 | 5.22 | 4.44 | 5.05 | 0.67 | 2.70 | 0.75 | 1.29 |
Free Cash Flow |
(15.36) | (6.61) | (44.66) | (73.78) | (67.31) | (38.94) | (214.85) | (322.28) | (273.69) | (20.37) |
Working Capital |
249.09 | 240.14 | 391.06 | 333.62 | 317.75 | 458.74 | 344.27 | 438.87 | 215.95 | 277.66 |
Capital Expenditures |
(11.92) | (14.01) | (19.70) | (15.56) | (24.57) | (24.15) | (28.56) | (42.26) | (36.21) | (58.16) |
Net Current Asset Value |
114.84 | 98.60 | 104.77 | 45.46 | 14.18 | 108.31 | (143.30) | 28.67 | (118.35) | (52.80) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.09 | 0.09 | 0.12 | 0.09 | 0.12 | 0.18 | 0.26 | 0.29 | 0.16 | 0.12 |
Net Profit Margin |
(35.86%) | (38.55%) | (62.51%) | (83.51%) | (85.43%) | (136.60%) | (254.41%) | (76.70%) | (137.90%) | (5.21%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
6.91 | 6.13 | 7.14 | 19.03 | 3.72 | 2.34 | 2.39 | 4.38 | 7.64 | 14.41 |
Cash ROIC |
(0.99%) | 0.65% | (2.85%) | (7.41%) | (6.62%) | (2.39%) | (22.49%) | (25.11%) | (32.81%) | 4.51% |
Accounts Receivable Turnover |
8.63 | 9.57 | 12.38 | 10.92 | 7.55 | 5.38 | 6.72 | 7.68 | 9.66 | 9.15 |
Accounts Payable Turnover |
0.60 | 0.27 | 0.43 | 0.31 | 0.32 | 0.28 | 0.27 | 0.39 | 0.24 | 0.43 |
Inventory Turnover |
1.70 | 0.88 | 1.01 | 0.89 | 0.90 | 0.51 | 0.75 | 1.64 | 0.99 | 1.71 |
Average Days of Payables |
602.88 | 1,917.44 | 459.24 | 1,855.96 | 722.91 | 1,447.76 | 1,427.79 | 1,328.50 | 1,109.23 | 875.52 |
Days of Inventory on Hand |
226.50 | 541.78 | 371.08 | 424.14 | 453.30 | 699.12 | 373.51 | 299.97 | 292.23 | 207.41 |
Average Receivables |
15.48 | 16.19 | 13.27 | 16.05 | 26.26 | 24.49 | 16.28 | 18.91 | 24.15 | 53.63 |
Average Payables |
7.58 | 13.23 | 12.95 | 16.78 | 19.37 | 13.64 | 16.22 | 29.48 | 32.60 | 24.17 |
Average Inventory |
2.68 | 4.09 | 5.49 | 5.85 | 6.85 | 7.46 | 5.92 | 6.97 | 7.81 | 6.04 |
Average Assets |
518.77 | 522.81 | 614.75 | 656.98 | 606.12 | 692.04 | 724.61 | 730.75 | 691.52 | 599.66 |
Average Common Equity |
303.87 | 300.45 | 305.69 | 269.72 | 216.20 | 256.66 | 172.48 | 121.83 | 129.94 | 86.95 |
Columns are period end dates